Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2022

View Archived Issues

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Storm Therapeutics identifies new METTL3 inhibitors

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

Lilly patents dopamine D1 receptor positive allosteric modulators

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

Hemispherian closes seed funding to advance preclinical pipeline for cancer

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

Ring Therapeutics describes in vitro system enabling human anellovirus production

Novel TRPC5 inhibitors show potential for the treatment of CKD

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...